An information resource for patients about the COVID vaccination and VITTs

A new Thrombosis UK free patient information resource provided for medical centres to share: 'COVID-19 vaccines and VITT', filmed interview addressing many FAQs about this very topical subject.
Professor Beverley Hunt OBE

Learning in obstetrics and gynaecological thrombosis

(a) Vaccination in pregnancy, safety monitoring and other considerations
Dr Kenneth Hodson

(b) Learning from COVID in thrombosis and pregnancy
Dr Jahnavi Daru

(c) Evidence and options in HRT and blood clots
Dr Louise Newson

Managing patients on warfarin – practical tips and case studies

(a) Managing skills, opportunities and challenges in a nurse led warfarin clinic
Hayley Flavell

(b) Tips and learning from an anticoagulation hospital service, pharmacist led
Victoria Collings

(c) Anticoagulation and the role of Primary Care
Dr Matthew Fay

Individual approach for the primary prophylaxis of postoperative VTE in patients at extremely high risk

Dr Kirill Lobastov

COVID and clots

(a) Current thoughts on the pathogenesis of COVID-19
Dr Yogen Kanthi

(b) Heparin as an anti-inflammatory and antiviral agent
Dr Andrew Webb

(c) Inhaled heparin – learning and research
Dr Quentin Nunes

VTE prevention in hospitalised psychiatric patients

This session will include examples and draw upon experience and learning in establishing Quality Improvement programmes that have led to the development of local protocols
Dr Josie Jenkinson
Dr Thomas York
Dr Ashma Mohamed
Dr Michael Cheah

Reversal of FXa inhibitor-related life-threatening or uncontrolled bleeds

To access the Ondexxya▼ (andexanet alfa) prescribing and adverse event reporting info, please click here.

Dr Raza Alikhan

Dr Will Thomas

Update on thromboprophylaxis and COVID

Update on thromboprophylaxis in hospitalised COVID-19 patients
Dr Dan Horner

Decision making on thromboprophylaxis for patients with COVID19 in the community (post discharge and those managed through a hospital at home mechanism)
Dr Susie Shapiro

Evidence update on Vaccine Induced Immune Thrombosis and Thrombocytopenia
Professor Beverley Hunt OBE

Reducing hospital acquired thrombosis – Learning from NHS GIRFT (Getting It Right First Time)

GIRFT findings
Dr Lara Roberts

Local impact and changes implemented as a result of GIRFT
Andrew Gillett

Panel discussion and Q&A session
Dr Lara Roberts, Emma Gee, Rebecca Simpson, Andrew Gillett

Identifying problem areas in thrombosis that need fresh ideas

(a) Will we ever develop a perfect anticoagulant?
Professor Helen Philippou

(b) Where are we going to improve quality and safety of imaging for VTE?
Dr Narayan Karunanithy

(c) Improving VTE risk assessment for thromboprophylaxis in UK hospitals
Professor Roopen Arya

Guidelines in Cancer Associated Thrombosis

(a)Updates in CAT international guidelines
Dr Raza Alikhan

(b) What is missing - gaps in evidence and research is needed
Professor Simon Noble

The challenges of managing VTE in a cancer patient

Professor Simon Noble

Professor Anthony Maraveyas

VTE in Pregnancy

Chaired by: Sylvia Teece-Round

Managing AF in the setting of COVID: Challenges and Opportunities

Chaired by: Sylvia Teece-Round

VTE Diagnosis in the Emergency Department

Chaired by: Sylvia Teece-Round

Delivery of anticoagulation management in the community, challenges and achievements

Chaired by: Sylvia Teece-Round

Achieving Exemplar Site Status

Chaired by: Sylvia Teece-Round

Treatment of VTE – an interactive session

Chaired by: Sylvia Teece-Round

COVID and PE

Chaired by: Sylvia Teece-Round